Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection

Patients with anti–IFN-γ autoantibodies have impaired IFN-γ signaling, leading to severe disseminated infections with intracellular pathogens, especially nontuberculous mycobacteria. Disease may be severe and progressive, despite aggressive treatment. To address the underlying pathogenic IFN-γ autoa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Browne, Sarah K., Zaman, Rifat, Sampaio, Elizabeth P., Jutivorakool, Kamonwan, Rosen, Lindsey B., Ding, Li, Pancholi, Minjal J., Yang, Lauren M., Priel, Debra Long, Uzel, Gulbu, Freeman, Alexandra F., Hayes, Carlton E., Baxter, Roger, Cohen, Stuart H., Holland, Steven M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350360/
https://ncbi.nlm.nih.gov/pubmed/22403254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-395707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars